Drugs / Microbiome Therapeutic
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05835206 | Apr 2024 → Sep 2027 expected | — | Emory University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Microbiome Therapeutic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05835206 ↗ |
| Modality | Other / unclassified | “lyophilized human intestinal microbiota” NCT05835206 ↗ |
| Route | Oral | “The capsules are to be taken orally with water on an empty stomach.” NCT05835206 ↗ |